Theravance Biopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.90
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
1
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-0.21
|
-0.03
|
-16.67%
|
|
2022-06-30
|
0.11
|
-0.11
|
-0.22
|
-200.00%
|
|
2022-03-31
|
-0.11
|
-0.34
|
-0.23
|
-209.09%
|
|
2021-12-31
|
-0.33
|
-0.43
|
-0.10
|
-30.30%
|
|
2021-09-30
|
-0.56
|
-0.48
|
0.08
|
14.29%
|
|
2021-06-30
|
-1.00
|
-0.80
|
0.20
|
20.00%
|
|
2021-03-31
|
-1.05
|
-1.24
|
-0.19
|
-18.10%
|
|
2020-12-31
|
-1.02
|
-0.92
|
0.10
|
9.80%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.66
|
|
2021-12-31
|
-2.95
|
|
2020-12-31
|
-4.48
|
|
2019-12-31
|
-4.26
|
|
2018-12-31
|
-4.00
|
|
2017-12-31
|
-5.45
|
|
2016-12-31
|
-4.25
|
|
2015-12-31
|
-5.34
|
|
2014-12-31
|
-5.29
|